Trending News EU – 31st August 2023

On this week’s Trending News EU episode, Jack and Ollie discuss a few recent EU-based newsworthy items including the potential for robotics to transform surgical and patient care (0.35), exciting progress being made in Europe to advance decentralised clinical trials (7.26), and much needed hope for those suffering with postpartum depression following approval in the US of an innovative new medicine (15.48). 

Podcast Tags: healthcare, healthcare news, robotics, AI, artificial intelligence, NHS, health equity, EU, clinical trials, neuroscience, depression, postpartum depression, major depressive disorder, biogen 

Source Links:  

• Outdated legacy tech risks driving frustrated staff out of the NHS 
• Millions of hours of doctors’ time lost each year to ‘inadequate’ IT systems 
• St Bartholomew’s perform first robotic-assisted lung biopsy 
• Is Outdated Technology Holding Back UK Surgeons? 
• The robotics revolution has arrived, and it is changing how we do surgery 
• €60 million committed to establish AI and robotics in healthcare 
• Robotic surgery supporting faster recoveries and better outcomes 
• Different, But Not Poles Apart: Running Decentralized Clinical Trials In EU & US 
• Principles-Based vs Prescriptive: How US & EU Compare In Their Approach To Decentralized Trials 
• How clinical trials benefit from decentralized solutions: A Nordic case study 
• The trial of the future: using digital technologies to enable decentralized trials 
• Decentralized trials getting some attention on the international regulatory front 
• No place like home? Stepping up the decentralization of clinical trials 
• A new pill in the U.S. offers hope to mothers with postpartum depression 
• Postpartum psychosis: new mothers speak out over need for support 
• Clinical Efficacy of a 2-Week Treatment Course of Zuranolone for the Treatment of Major Depressive Disorder and Postpartum Depression: Outcomes From the Clinical Development Program 
• Impact of new pill to treat postpartum depression will depend on price 
• Biogen, Sage's postpartum depression approval overshadowed by larger rejection 

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC. 

Jen Burke, Director  

Jen.Burke@vynamic.com 

Jack Young, Senior Director 

Jack.Young@vynamic.com 

Oliver May, Senior Manager  

Oliver.May@vynamic.com